![](/img/cover-not-exists.png)
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
Elez, Elena, Pericay, Carles, Valladares-Ayerbes, Manuel, Bando, Inmaculada, Safont, Maria Jose, Gallego, Javier, Grávalos, Cristina, Arrivi, Antonio, Carrato, Alfredo, Conde, Verónica, Ortiz, Maria JLanguage:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-019-0537-z
Date:
July, 2019
File:
PDF, 387 KB
english, 2019